Investigative Site

Edmonton, Alberta T6G2B7

0 studies enrolling now · 3 studies all time

What they study most

Atrial Fibrillation, Atrial Flutter, End-Stage Renal Disease (ESRD), Psoriasis

Studies at this site

• A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis — Completed
• Dose Ranging Study of Dialysate Containing Soluble Iron to Treat Subjects With End Stage Renal Disease (ESRD) Receiving Chronic Hemodialysis — Completed
• Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter — Completed